OncoInv signs distribution agreement for OncoSeek® in El Salvador

November 27, 2025

OncoInv has signed a new distribution partnership with MaxBloch Clinical Laboratories in El Salvador, expanding the reach of its OncoSeek® multi-cancer detection blood test to Central America.

The agreement marks another step in OncoInv’s international growth strategy and its commitment to making early cancer detection affordable and available to all. The collaboration will enable healthcare providers in El Salvador to access OncoSeek®, a CE-marked diagnostic test designed to detect nine of the world’s most lethal cancers from a single blood sample.

“This partnership is part of our ongoing mission to bridge global health inequalities,” said Jesper Verhey, CCO, OncoInv. “The cancer burden is growing, but so is our ability to act. Multi-cancer detection is not about if, but when and how we come together to make it a reality for all. By joining forces with MaxBloch SA de CV, we bring OncoSeek® closer to the people who need it most.”

OncoSeek® combines widely accessible laboratory technology with advanced machine learning analysis, offering a low-cost and scalable solution suitable for both high-income and resource-limited settings. The product is offered not-for-profit in the public sector in low- and middle-income countries.

About MaxBloch Clinical Laboratories

MaxBloch Clinical Laboratories is one of El Salvador’s most established providers of clinical diagnostic services, with a history spanning more than 80 years. Founded by Dr. Max Bloch, an internationally recognised physician and researcher, the organisation has grown into a nationwide network of laboratory centres offering a wide range of routine and specialised tests. MaxBloch is known for its scientific rigor, patient-centred approach and strong commitment to ethical practice, refraining from financial incentives to referring physicians. The organisation operates under internationally aligned quality standards, including ISO 15189:2022, ensuring reliable and accessible diagnostics for communities throughout El Salvador.

For more information about MaxBloch Clinical Laboratories, visit www.maxbloch.com

Click here for more information about OncoSeek®

More news

Nigeria’s Ministery of Health champions early cancer detection through strategic innovation

July 1st, 2025

The Nigerian Ministry of Health is taking decisive steps to address the urgent need for early cancer detection across the country. “It is time for Nigeria to fully embrace the power of early detection. This is not a luxury—it is a necessity in our battle against cancer,” stated Dr. Iziaq Kunle Salako, Minister of Health and Social Welfare...

Read more
Accelerating early cancer detection in Latin America: Biotecgen enters strategic partnership with OncoInv

June 10th, 2025

Biotecgen (Colombia) and OncoInv (The Netherlands) have joined forces to make multi-cancer early detection accessible in Colombia. Biotecgen will offer OncoSeek®, a patient-friendly solution for cancer detection, requiring only a blood sample to detect 9 types of cancer...

Read more
Longevity Medical Institute launches advanced cancer early detection program in Mexico using oncoseek test

April 7th, 2025

Longevity Medical Institute™ (LMI), a leading centre for regenerative medicine and diagnostics in Mexico, has partnered with OncoInv to incorporate the OncoSeek® test into one of the most advanced and accessible cancer detection programs in Latin America...

Read more